Franklin Genomic Advancements ETF (HELX)
BATS: HELX · Real-Time Price · USD
27.89
+0.25 (0.91%)
Aug 8, 2025, 4:00 PM - Market closed
HELX Holdings Information
HELX is an equity ETF with a total of 66 individual holdings. The top holdings are Natera stock at 5.59%, Alnylam Pharmaceuticals at 5.04%, Medpace Holdings at 4.41%, Samsung Biologics at 4.16%, and Guardant Health at 4.12%.
Total Holdings
66
Top 10 Percentage
40.39%
Asset Class
Equity
ETF Category
Health
Assets
13.84M
PE Ratio
27.95
Sector Allocation
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | NTRA | Natera, Inc. | 5.59% |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.04% |
| 3 | MEDP | Medpace Holdings, Inc. | 4.41% |
| 4 | KRX: 207940 | Samsung Biologics Co.,Ltd. | 4.16% |
| 5 | GH | Guardant Health, Inc. | 4.12% |
| 6 | INSM | Insmed Incorporated | 3.60% |
| 7 | VRTX | Vertex Pharmaceuticals Incorporated | 3.51% |
| 8 | n/a | Us Dollar | 3.43% |
| 9 | KRYS | Krystal Biotech, Inc. | 3.34% |
| 10 | CTVA | Corteva, Inc. | 3.17% |
| 11 | AZN | AstraZeneca PLC | 2.98% |
| 12 | UTHR | United Therapeutics Corporation | 2.80% |
| 13 | BBIO | BridgeBio Pharma, Inc. | 2.70% |
| 14 | BNTX | BioNTech SE | 2.69% |
| 15 | LLY | Eli Lilly and Company | 2.65% |
| 16 | CDNS | Cadence Design Systems, Inc. | 2.63% |
| 17 | REGN | Regeneron Pharmaceuticals, Inc. | 2.25% |
| 18 | ADPT | Adaptive Biotechnologies Corporation | 2.15% |
| 19 | LGND | Ligand Pharmaceuticals Incorporated | 2.07% |
| 20 | TMO | Thermo Fisher Scientific Inc. | 1.92% |
| 21 | DHR | Danaher Corporation | 1.89% |
| 22 | ETR: SRT3 | Sartorius Aktiengesellschaft | 1.87% |
| 23 | QGEN | Qiagen N.V. | 1.79% |
| 24 | TEM | Tempus AI, Inc. | 1.75% |
| 25 | SWX: LONN | Lonza Group AG | 1.53% |
As of Aug 8, 2025